Skip to main content
Gastrointestinal Cancers
Ramucirumab plus Paclitaxel Confers an Overall Survival Advantage Over Placebo in the RAINBOW-Asia Study
Read More
Gastrointestinal Cancers
Zolbetuximab in Combination with Epirubicin/Oxaliplatin/Capecitabine Shows Survival Advantage in Patients with Gastric, Gastroesophageal Junction, and Esophageal Cancer: The FAST Study
Read More
Gastrointestinal Cancers
Second-Line Nivolumab with Paclitaxel plus Ramucirumab Shows Promising Antitumor Responses in Patients with Advanced Gastric Cancer
Read More
Online First Meeting Highlights
ESMO 2021 Highlights
Study Shows mRNA COVID-19 Vaccine Effective and Safe in Patients with Cancer Undergoing Treatment
Read More
Online First Meeting Highlights
ESMO 2021 Highlights
Trastuzumab Deruxtecan Tops Trastuzumab Emtansine as Second-Line Therapy in HER2-Positive Metastatic Breast Cancer
Read More
Online First Meeting Highlights
ESMO 2021 Highlights
Abiraterone Added to Androgen-Deprivation Therapy Significantly Improves Metastasis-Free Survival in Patients with High-Risk Prostate Cancer
Read More
Online First Meeting Highlights
ESMO 2021 Highlights
Adagrasib Shows Promising Activity in Metastatic Colorectal Cancer
Read More
RESOLVE: Significant Improvement in 3-Year Disease-Free Survival with Use of Perioperative SOX in Patients with Locally Advanced Gastric Cancer
Read More
Zanidatamab plus Standard First-Line Chemotherapy Demonstrates Promising Antitumor Activity in Patients with HER2-Positive GEA
Read More
DESTINY-Gastric02: Clinical Efficacy Found with Use of Second-Line Trastuzumab Deruxtecan in Patients with Metastatic Gastric or Esophageal Junction Cancer
Read More
Page 80 of 199
Results 791 - 800 of 1986